Mezin-Koats Colon Cancer Research Award
The objective of the Mezin-Koats Colon Cancer Research Award is to support research in the biology, prevention, detection, diagnosis, and/or treatment of colon cancer.
The award is made possible by the generous support of Mezin-Koats Colon Cancer Research. The mission of Mezin-Koats Colon Cancer Research at the Masonic Cancer Center, University of Minnesota, is to advance the knowledge around the treatment of colon cancer with the hope of improving the quality of life and outcomes for people battling this disease.
Grantees
Characterization of microbiome-associated biomarkers in a clinical trial of probiotics in colon cancer
Ajay Prakash, MD, PhD, Division of Hematology, Oncology, and Transplantation, Medical School
Subree Subramanian, PhD, Department of Surgery, Medical School
Targeting Amino Acids Transporter LAT1 as a Novel Approach in Colorectal Cancer Therapy
Subree Subramanian, PhD, Department of Surgery, Medical School
Andrew Nelson, MD, PhD, Department of Laboratory Medicine and Pathology, Medical School
Emil Lou, MD, PhD, FACP, Division of Hematology, Oncology, and Transplantation, Medical School
The role of polyp location in surveillance time intervals of colorectal cancer screening
Paolo Goffredo, MD, Colon & Rectal Surgery, Medical School
Investigating the Role of LAT1 Inhibition in Modulating Macrophage Polarization and Improving Antitumor Immune Response in Colorectal Cancer
Subree Subramanian, PhD, Department of Surgery, Medical School
Role of CEP55 in Colorectal Cancer Tumor Progression and Immune Regulation
Subree Subramanian, PhD, Department of Surgery, Medical School
Timothy Starr, PhD, Obstetrics, Gynecology and Women's Health, Medical School
Andrew Nelson, MD, PhD, Department of Laboratory Medicine & Pathology, Medical School
The Role of Adenovirus Death Protein on NIS-mediated Bioimaging in Metastatic Colorectal Cancer
Christopher LaRocca, MD, Division of Surgical Oncology, Medical School
Julia Davydova, MD, PhD, Department of Surgery, Medical School
Eric Jensen, MD, Division of Surgical Oncology, Medical School
Risk factors and Mechanisms for early onset Colorectal Neoplasia
Justin Ryder, PhD, Department of Surgery, Medical School
Aasma Shaukat, MD, PhD, Division of Environmental Health Sciences, School of Public Health
Anna Prizment, PhD, Division of Hematology, Oncology and Transplantation, Medical School
The role of CFTR deficiency in oxidative stress tolerance and colorectal cancer
Patricia Scott, University of Minnesota - Medical School - Biomedical Sciences - Duluth campus
Division of Hematology, Oncology and Transplantation, Department of Medicine, Medical School
Host-microbiome Metabolic Interactions in Colorectal Cancer
Subree Subramanian, PhD, Department of Surgery, Medical School
Investigating underlying mechanisms of KCNQ1 tumor suppression using colorectal cancer liver metastasis-derived organoid models
Robert Cormier, PhD, Department of Biomedical Sciences – Duluth Campus, Medical School
The role of PELP1 and PELP1 mutations in colorectal cancer biology
Julie Ostrander, PhD, Department of Medicine, Medical School
Role of ACKR4 in regulation of immune response in colorectal cancer
Subree Subramanian, PhD, Department of Surgery, Medical School
Timothy Starr, PhD, Department of Obstetrics, Gynecology, and Women's Health, Medical School
Mechanisms Underlying the Tumor Suppressor Role of CFTR in Colorectal Cancer
Patricia Scott, PhD, Department of Biomedical Sciences, Medical School, UMD
Role of Intercellular Transfer of KRAS in Promoting Colon Cancer Resistance
Emil Lou, MD, PhD, Department of Medicine, Medical School
Developing Personalized, Targeted Therapy for Colorectal Cancer Patients
Tim Starr, PhD, Department of Obstetrics, Gynecology and Women’s Health, Medical School